International Journal of Pharmaceutical Investigation, 2013, 2, 4, 218.
DOI: 10.4103/2230-973X.107008
Published: February 2013
Type: Letter to Editor
Authors:
Viroj Wiwanitkit
Wiwanitkit House, Bangkhae, Bangkok, Thailand, Hainan Medical University, China, Joseph Ayobabalola University, Nigeria, Faculty of Medicine, University of Nis, Serbia.
ABSTRACT
The editorial on delivery of nutraceuticals using nanotechnology is very interesting.[1] As noted, successful formulation of new nanosubstance is the hope. However, the effectiveness and safety is still the consideration.[1,2] The concern is further testing of the new nano‑product. A good testing system is needed. Generally in vitro experiment might be convenient but it cannot answer the question. There are many concerns of the nano‑products. The in vivo stability of the new product must be studied. Indeed, the nanosubstance is usually highly sensitive and aggregation can easily occur. As a result, changes in the physical and biochemical properties can be expected. On the other hand. Read more…
Keywords: Nil.